IGCL · Indogulf Cropsciences Ltd · Chemical Manufacturing
IGCL · Indogulf Cropsciences Ltd · Chemical Manufacturing
As of 05 Nov close
52-week range
41.5% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹169 Cr
Revenue YoY
PAT YoY
-37.7%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
0.9
P/S (TTM)
0.6
Sector P/E
20.6
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| IGCL (this stock) | 9.9 | 0.9 | +5.6% | +8.4% | 0.4 | 0.0% |
| Asian Paints | 53 | 11.1 | +12.8% | +22.3% | 0.18 | +1.1% |
| Solar Industries India | 99.6 | 26.6 | +17.6% | +31.4% | 13.68 | +0.1% |
| Pidilite Industries | 61.3 | 19.4 | +17.2% | +24.4% | 0.04 | +0.7% |
Promoter
stable
FII
stable
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: Indogulf Cropsciences Ltd. reported Q1 FY27 revenue of Rs. 168.5 crores, a 11% year-over-year decline, attributed to delayed monsoons affecting agricultural cycles and reduced crop protection demand. However, gross margins improved to 28% from 22% in Q1 FY26, and EBITDA margins rose to 5.7% from 5.2%. Capacity utilization increased to 70% compared to 52% in FY26. Management highlighted challenges from weak demand, pricing pressures, and uneven rainfall, but emphasized resilience in portfolio diversification and operational efficiency. Strategic initiatives include expanding biological and sustainable product portfolios, enhancing farmer engagement, and global market expansion, with registrations in countries like Taiwan, Sri Lanka, and Saudi Arabia. The company noted ongoing investments in manufacturing and distribution, with a focus on specialty products and long-term growth. Management declined to provide specific growth targets for FY27 but indicated capacity upgrades could support revenue up to Rs. 1800 crores in 4-5 years. The discussion also covered backward integration efforts, with captive consumption of technicals at 34%, and plans to leverage new technologies and collaborations for future product development.
The summary presents factual results, challenges, and strategic directions without overtly positive or negative language.
Sourced from an exchange-filed transcript, dated 21 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Indogulf Cropsciences Limited submitted a revised earnings call presentation for Q1 FY 2026-27 to rectify clerical errors from a previous submission. The presentation outlined the company's focus on evolving from a product-centric approach to an integrated agri-solutions platform, emphasizing innovation, sustainability, and deeper farmer engagement. Key highlights included a diversified product portfolio, strong farmer engagement with over 100,000 farmers, and a robust distribution network across 36 countries. Financial performance for Q1 FY27 showed a revenue of INR 1,685 million, a decrease of 11% year-over-year, with EBITDA at INR 96 million and PAT at INR 24 million. The document also detailed strategic goals for expanding biological products, enhancing operational excellence, and accelerating global expansion. Management expressed a commitment to sustainable growth and long-term value creation.
The presentation provided a balanced overview of the company's operations and financial performance.
Sourced from an exchange-filed presentation, dated 18 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Indogulf Cropsciences Limited submitted an investor presentation detailing its Q1 FY 2026-27 financial results and strategic initiatives. The presentation highlighted a revenue of INR 7,046 million, reflecting a 19% year-over-year increase, with EBITDA at INR 740 million and a PAT of INR 400 million, marking a 27% increase. Management emphasized the company's transition from a product-focused approach to an integrated agri-solutions platform, aiming to enhance farmer engagement and sustainability. The document outlined key strengths, including a diversified product portfolio, robust manufacturing capabilities, and a strong distribution network. Additionally, it reported on the company's global expansion efforts and commitment to innovation in crop protection and biological solutions. The presentation concluded with a roadmap for future growth, focusing on deepening farmer engagement and expanding into new markets.
Management emphasized growth and strategic initiatives aimed at enhancing value creation.
Sourced from an exchange-filed presentation, dated 14 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Indogulf Cropsciences Limited held its Q4 FY26 Earnings Conference Call on May 29, 2026, where management discussed the company's performance and strategic initiatives. Management reported a 19% revenue growth for FY26, reaching INR 705 crores, driven by a diversified business model and strong domestic execution. Despite challenges in the agrochemical industry, including weather-related issues and supply chain disruptions, the company maintained operational stability. Key highlights included the expansion of their distribution network, successful international shipments, and improvements in manufacturing capacity utilization, which rose to 52%. Management emphasized their integrated agri-solution approach and ongoing investments in innovation and research. The call also addressed the impact of potential El Nino conditions and geopolitical tensions on the industry, while expressing confidence in long-term growth opportunities. The CFO provided insights into financial performance, noting stable profit margins despite cost pressures.
The document presented both achievements and challenges faced by the company.
Sourced from an exchange-filed transcript, dated 02 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Indogulf Cropsciences Limited's investor presentation for Q4 and FY26 detailed the company's financial performance, reporting a revenue of INR 7,046 million for FY26, reflecting a 19% year-over-year increase. EBITDA for the same period was INR 740 million, up 15% year-over-year, while PAT reached INR 400 million, a 27% increase. The presentation highlighted a balanced revenue mix, with 85% from crop protection, 6% from biologicals, and 5% from plant nutrients. Management emphasized the company's commitment to innovation, sustainability, and deepening farmer engagement through an advisory-led approach. The document also outlined strategic goals for future growth, including expanding the biologicals portfolio and accelerating global expansion into new markets. The presentation concluded with a focus on operational excellence and innovation-led growth as key drivers for long-term value creation.
Management emphasized growth and strategic initiatives for future expansion.
Sourced from an exchange-filed presentation, dated 28 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the Q3 FY26 Earnings Conference Call held on February 12, 2026, management reported a 17% year-on-year revenue growth, driven by strong performance in both B2C and B2B segments despite a challenging operating environment. The Managing Director, Sanjay Aggarwal, highlighted the successful execution of their distribution strategy and the positive impact of Abhiprakash Globus Private Limited, which achieved gross sales of INR 54 crores in its first full year. The CFO, Manoj Gupta, detailed financial performance, noting a 16% increase in EBITDA and a profit after tax of INR 39 million, impacted by higher tax provisions. Management discussed the potential for growth in Q4 FY26 and Q1 FY27, supported by improving market sentiment and new market entries. They emphasized the importance of their diversified portfolio and strategic investments in distribution and product capabilities. The call concluded with management expressing confidence in their growth trajectory and commitment to stakeholder value.
Management emphasized strong performance and growth potential despite challenges.
Sourced from an exchange-filed transcript, dated 17 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Indogulf Cropsciences Limited reported a resilient performance in Q3 FY26, with a revenue growth of 17% year-on-year, attributed to strong traction in both B2C and B2B segments. Management highlighted that the growth momentum for 9M FY26 was 19% year-on-year, supported by steady demand in key agricultural states and a focused distribution strategy. The presentation noted that the company successfully entered the Venezuela market, securing initial orders. Financial highlights included an EBITDA increase of 16% year-on-year for Q3, driven by a favorable product mix and improved cost management. However, PAT was lower due to higher tax provisioning. Management expressed cautious optimism regarding demand recovery, citing stabilization of crop prices and improved rural liquidity. The document also outlined the company's strategic initiatives, including expanding production capacities and enhancing its product portfolio.
Management emphasized strong growth and strategic initiatives despite industry challenges.
Sourced from an exchange-filed presentation, dated 12 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedIndogulf Cropsciences Limited (IGCL) emphasizes its strategic evolution beyond traditional agrochemical products, focusing on integrated crop solutions, sustainability, and farmer engagement. The report highlights the company's IPO in FY2025, expansion of manufacturing capacity, and investments in research and development, including patents for specialized crop protection technologies. IGCL also outlines its commitment to corporate governance, stakeholder communication, and addressing global and regional economic uncertainties impacting the agriculture sector.
- Strategic focus on evolving beyond product-centric models to integrated agri-solutions platforms with global reach.
- Commitment to research and development, including patents for crop protection technologies tailored to Indian agronomic needs.
- Strengthening farmer engagement through initiatives like 'Farmer’s Connect' and digital platforms for real-time data and decision support.
- Corporate governance and compliance with SEBI and MCA regulations, including transparent reporting and stakeholder communication.
- Expansion of manufacturing capacity and global market presence, supported by a post-IPO balance sheet for financial resilience.
Key takeaway: Indogulf Cropsciences is transitioning from a product-focused entity to a comprehensive agri-solutions provider, emphasizing sustainability, research, and global expansion while navigating macroeconomic and industry-specific challenges.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
1 occurrenceRecent (last 12 months)
The company has contingent liabilities from cash credit facilities secured against personal guarantees by directors Om Prakash Aggarwal, Sanjay Aggarwal, and Anshu Aggarwal, as well as corporate guarantees from Om Prakash HUF and Sanjay Aggarwal HUF.